Zydus announces completion of Enrolment for Phase II clinical trial of Usnoflast
ALS is a rare, progressive and fatal neurodegenerative disease, with an average life expectancy of 3 to 5 years from the time of symptom onset
ALS is a rare, progressive and fatal neurodegenerative disease, with an average life expectancy of 3 to 5 years from the time of symptom onset
Theophylline is used to treat asthma and chronic obstructive pulmonary disease
Updated results from the four studies will be presented in Oral Reports or Posters at the ASCO Annual Meeting
The acquisition is immediately accretive and creates a compelling, single-stop, multi-continent partner for biopharma companies
The combined entity will enable us to better serve the needs of patients, healthcare professionals and our customers around the world
Acquisition will advance Merck’s integrated offering for viral vector manufacturing
Establishing Asymchem’s first manufacturing footprint in Europe
Cipla's Lanreotide Injection is AP-rated therapeutic equivalent generic version of Somatuline Depot (Lanreotide) Injection
Operationally ready by 2029, it will be the Company’s first-ever facility to cover the full manufacturing process for ADCs
ASG Group of Eye Hospitals has 165+ branches in 85+ cities across India and abroad
Subscribe To Our Newsletter & Stay Updated